Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2011-03-10 Legal Proceedings Report
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
MCNEIL-PPC, INC. CONSENT DECREE 8-K
Legal Proceedings Report Classification · 95% confidence The document is a Form 8-K filing with the SEC, which is used for current reports on significant events. The text references a Consent Decree with the FDA and includes a press release as an exhibit. The document is short (2608 characters) and primarily announces an event rather than providing detailed financial data or a full report. It does not contain financial statements or detailed management discussion. The nature of the content is an announcement of a legal/regulatory event involving the company. Therefore, it fits best under Legal Proceedings Report (LTR) as it updates on a significant regulatory/legal matter involving the company.
2011-03-10 English
SC TO-T/A Filing
M&A Activity Classification · 100% confidence The document is a Schedule TO and Schedule 13D filing related to a tender offer under the Securities Exchange Act of 1934. It includes detailed information about the tender offer, amendments to previous filings, share ownership percentages, and intentions regarding delisting and buy-out proceedings. The document is regulatory in nature, related to a merger/acquisition transaction, specifically a tender offer and acquisition of shares. The presence of terms like 'Tender Offer Statement', 'Schedule TO', 'Schedule 13D', and references to the Securities Exchange Act, along with detailed transaction valuation and filing fees, clearly indicate this is a filing related to M&A activity. It is not a general regulatory announcement or a simple report publication announcement, but a formal filing for a takeover bid. Therefore, the appropriate classification is 'TAR' (M&A Activity). The document length and content confirm it is a full filing, not just an announcement or summary.
2011-03-08 English
FORM S-3ASR
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 registration statement filed with the SEC by Johnson & Johnson. It is a registration statement under the Securities Act of 1933 for the offering of debt securities and warrants. The document includes a prospectus describing the securities to be offered, the company's business segments, and other related information. It is not an annual report, earnings release, or any other financial report but a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, so it is not a Report Publication Announcement or Regulatory Filing. Confidence is high given the clear identification as a Form S-3 registration statement for securities offering.
2011-02-28 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2011-02-25 English
FORM 10-K
Annual Report FY 2011
2011-02-25 English
SC TO-T/A Filing
M&A Activity Classification · 100% confidence The document is a Schedule TO and Schedule 13D filing related to a tender offer under the Securities Exchange Act of 1934. It includes detailed information about the tender offer, amendments to previous filings, share ownership percentages, and procedural details about the offer and subsequent offering period. The presence of terms like 'Tender Offer Statement', 'Schedule TO', 'Schedule 13D', and references to Sections 14(d)(1) and 13(e)(1) of the Exchange Act clearly indicate this is a filing related to a tender offer transaction. This type of filing is specifically related to merger and acquisition activity, as it involves an offer to purchase shares and acquisition of control. Therefore, the appropriate classification is 'M&A Activity' (Code: TAR). The document length and content confirm it is not a mere announcement but a substantive filing. Confidence is high due to explicit references to tender offer and acquisition terms.
2011-02-22 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.